Climacteric : the journal of the International Menopause Society, 21(2), 111122
Michelle Gourdine, Chief Medical Officer, CVS Caremark
Mounjaro is administered through a once-weekly injection, similar to most GLP-1 receptor agonists, but its dual mechanism offers a potentially more comprehensive approach to managing diabetes symptoms and body weight
Key Takeaway: The subcutaneous delivery method is specifically chosen because it provides a steady absorption rate with minimal nerve interference, resulting in a more comfortable experience
Like other GLP-1 weight-loss injections, Wegovy helps you feel fuller for longer
The following are some known safety considerations that a prescribing healthcare provider will monitor for in patients taking semaglutide